| __timestamp | AbbVie Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 13673000 |
| Thursday, January 1, 2015 | 4285000000 | 14358000 |
| Friday, January 1, 2016 | 4366000000 | 12203000 |
| Sunday, January 1, 2017 | 4982000000 | 18125000 |
| Monday, January 1, 2018 | 10329000000 | 17071000 |
| Tuesday, January 1, 2019 | 6407000000 | 20018000 |
| Wednesday, January 1, 2020 | 6557000000 | 32788000 |
| Friday, January 1, 2021 | 7084000000 | 44966000 |
| Saturday, January 1, 2022 | 6510000000 | 311681000 |
| Sunday, January 1, 2023 | 8453000000 | 77707000 |
| Monday, January 1, 2024 | 12791000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, AbbVie Inc. has consistently outpaced Lantheus Holdings, Inc. in R&D investments. From 2014 to 2023, AbbVie's R&D expenses surged by approximately 156%, peaking in 2018 with a remarkable 10 billion dollars. In contrast, Lantheus Holdings, Inc. demonstrated a more modest growth, with a notable spike in 2022, where R&D spending increased by over 600% compared to 2014.
This strategic focus on R&D underscores AbbVie's aggressive pursuit of new therapies and treatments, while Lantheus Holdings, Inc. appears to be ramping up its efforts in recent years. As the pharmaceutical industry continues to evolve, these investments will likely play a pivotal role in shaping the future of healthcare innovations.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Zoetis Inc.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Spending Showdown: AbbVie Inc. vs Vericel Corporation
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.